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Rapid advances have been made in the field of 
respiratory therapy in the past several years , resulting 
in an increasing sophistication and range of appli-
cation . Properly applied, these modalities have led to 
significantly increased survival in patients with acute 
respiratory failure and a decreased morbidity among 
individuals with chronic pulmonary insufficiency . It 
is the purpose of this article to put into perspective 
respiratory therapy techniques and their application 
in the treatment of acute respiratory failure . To this 
end, we may divide respiratory therapy into five cate-
gories: I) oxygen delivery, 2) airway hygiene, 3) ex-
pansion therapy (lung inflation), 4) artificial airways, 
and 5) mechanical ventilation. 
While the symptoms are not specific, the onset of 
acute respiratory failure is not a subtle event. Abnor-
mal arterial blood gases are invariably present. In-
deed, the entity is usually defined in terms of the 
degree of alteration in the arterial blood gases. Acute 
respiratory failure results from one of three general 
abnormalities: I) neuromuscular dysfunction, 2) in-
creased airway resistance, and 3) reduction of pul-
monary compliance. In pure form each of these cate-
gories produces a predictable pattern of arterial 
blood gas derangement. Rational management of 
acute respiratory failure requires an awareness of 
these alterations so that the respiratory therapy may 
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be intelligently applied to stabilize or reverse the pa-
tient's pulmonary deterioration . 
In the initial assessment of the patient in acute 
respiratory distress, it is important to determine the 
nature of the respiratory compromise. Patients with 
neuromuscular dysfunction such as occurs with drug 
overdose or Guillain-Barre syndrome may have nor-
mal lungs but do not have the ability to maintain an 
adequate minute ventilation . The arterial blood gas 
derangement consists of hypoxemia and relatively 
acute hypercarbia with a normal alveolar-arterial ox-
ygen tension gradient. Respiratory failure due to a 
sudden increase in airway resistance includes entities 
such as status asthmaticus, or bronchospasm with 
retained secretions in patients with underlying 
chronic airway disease. The arterial blood gas analy-
sis will reveal hypoxemia with hypercarbia and a 
widened alveolar-arterial oxygen tension gradient. 
The functional residual capacity is elevated and, in 
many patients, there is actually an increase in pul-
monary compliance. The gas exchange abnormality 
results from ventilation-perfusion mismatching. Pa-
tients whose respiratory failure results from an acute 
loss of pulmonary compliance are those with an over-
whelming parenchymal insult such as occurs with 
extensive bacterial pneumonia, aspiration, or a sys-
temic process such as pancreatitis. These disorders 
may be grouped under the heading of adult respi-
ratory distress syndrome. The physiologic alterations 
are hypoxemia with hypocarbia and respiratory alka-
losis because of right-to-left shunting of blood, a fall 
in the pulmonary compliance, and a marked reduc-
tion in the functional residual capacity . 
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Hypoxemic Hypercapneic Respiratory Failure with 
Normal A-a 0 2 Gradient 
The Respiratory Therapy Department of an in-
stitution becomes involved with these patients when 
the decision has been made to institute mechanical 
ventilation. While the initial selection of artificial air-
ways is not in the domain of this department, usually 
it is the respiratory therapists who are called upon 
when these airways do not function properly. Be-
cause of the experience gained in managing airway 
problems, we at the Medical College of Virginia have 
developed a number of recommendations for this 
aspect of respiratory care. When selecting an artificial 
airway, one must make an initial decision between 
"compliant" and "stiff" cuffs. We prefer to use the 
large volume compliant cuff tubes because a seal is 
obtained at a lower cuff pressure. Furthermore, the 
intracuff pressure measured by the respiratory thera-
pist is a more accurate assessment of pressure exerted 
against the tracheal wall than pressures obtained 
from stiff cuffs. 
While orotracheal tubes may be rapidly inserted 
during an emergency such as a drug overdose, these 
tubes are associated with the highest incidence of 
tracheal damage since they are difficult to stabilize 
and have a tendency to move about in the trachea 
when the f)atient is turned, m_oves or coughs. Na-
sotracheal tubes are more stable and, when a com-
pliant cuffed tube is placed via this route, they may be 
left in place for as long as two to three weeks with a 
minimum of tracheal damage. The cross-sectional 
diameter of the nasotracheal tube is smaller than the 
orotracheal tube. The combination of longer length 
and the narrow diameter may make adequate suc-
tioning difficult. Should the management of secre-
tions be a problem and a prolonged intubation antici-
pated, elective tracheostomy offers many advantages 
such as the wide variety of tubes available, including 
talking tracheostomy tubes, fenestrated tubes, and 
cuffiess tubes; patients may be fed via the oral route; 
vocal cords are not damaged; and there is no damage 
to the nasal septum. With the advent of the compliant 
cuff and better management of the artificial airway, 
the incidence of tracheal damage has decreased sig-
nificantly. It does occur from time to time, however, 
and we stress the importance of periodic monitoring 
of intracuff pressure. 
When the decision has been made to intubate 
patients with this form of respiratory failure, and the 
appropriate airway has been selected, mechanical 
ventilation is usually instituted with relative ease be· 
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cause of the normal physiology of the underlying 
lung. 
Hypoxemic Hypercapneic Respiratory Failure with 
Abnormal A-a 0 2 Gradient 
This disturbance is most frequently found in pa-
tients with increased airway resistance due to bron-
chospasm, obstructing secretions, and mucosa] swel-
ling and edema. The immediate approach to the 
hypoxemic patient is to stabilize the arterial oxygen 
tension while treating the underlying defect in hopes 
of avoiding intubation. The goal is to maintain the 
Pao2 in the range of 60 to 80 mm Hg which will insure 
hemoglobin saturation in excess of 90%. Further in-
creases in the arterial oxygen tension do not signifi-
cantly increase oxygen delivery to the tissues. The 
mode of oxygen administration is of great impor-
tance in the presence of hypercapnia. Oxygen therapy 
devices are divided into high-flow or low-flow sys-
tems. A high-flow apparatus mixes oxygen and room 
air prior to delivery to the patient. The gas flow 
delivered by the device is sufficient to provide the 
patient's total minute ventilation. Low-flow systems 
do not provide enough gas flow to supply the entire 
inspired atmosphere, and some part of the tidal vol-
ume will be supplied by the entrainment of room air. 
Such systems may provide any concentration of oxy-
gen from 21 % to 95%, but the fraction of inspired 
oxygen (F 10 2 ) can be altered by the patient's respi-
ratory pattern. Low-flow devices include the nasal 
cannula and mask oxygen and may be used when the 
tidal volume of the patient is between 300 and 700 cc, 
the ventilatory rate is less than 30/ min, and there is 
relatively stable ventilatory pattern with time. Be-
cause of the potential danger of excess oxygen admin-
istration, we prefer to keep the F10 2 as low as is 
consistent with adequate oxygen delivery to the tis-
sues. The unpredictability of the tidal volume and 
minute ventilation in an acutely ill patient are reasons 
why we generally recommend high-flow oxygen sys-
tems; the most commonly used of these are masks 
that work on the Venturi principle. The standard 
inspired 0 2 fractions available are 24%, 28%, 35%, 
and 40%. Humidifiers are not required with these 
masks because the major portion of inspired gas is 
room air. To supply a high flow of oxygen in excess of 
40%, special systems can be a rranged by the Respi-
ratory Therapy Department. 
The importance of the mucociliary escalator in 
maintaining airway homeostasis is often under-
estimated. If the mucous blanket becomes dry or 
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abnormally thick, secretions . will not mobilize nor-
mally and cough will become ineffective, leading to 
dramatic increases in airway resistance. The most 
effective means of reestablishing the mucous blanket 
is to hydrate the tracheobronchial tree. Water may be 
delivered to the airway in molecular form as humidi-
fication or in particulate form as an aerosol. Simple 
bubble-type humidifiers are sufficient for patients 
with an intact upper airway. Should the nasopharynx 
be bypassed by an artificial airway' a heater is added 
to the humidifier to further increase water content. If 
one wishes to deliver particulate water or medications 
to aid bronchial hygiene, a nebulizing device should 
be used. Ultrasonic nebulizers produce a very heavy 
water mist with uniform particle size on the order of 
.5µ, to 3µ,. Jet nebulizers, which operate on the Ber-
noulli principle, may be used for aerosolization of 
both water and medications. Droplets are propelled 
against baffles which eliminate the larger and heavier 
particles since droplets of greater than IOµ, in size are 
clinically useless as they dci not deposit in the 
tracheobronchial tree. Aerosolized medications in-
clude mucolytics, bronchodilators, vasoconstrictors, 
and steroids. In addition to instillation of water into 
the airway, efforts have been made to change the 
viscosity of the secretions by nebulizing sodium bi-
carbonate or acetylcysteine. Usually these agents are 
no better at mobilizing dried secretions than good 
hydration; however, in circumstances where the 
mucous is abnormal, such as cystic fibrosis, they may 
be useful. They may also be successfully used in those 
patients where active oral or intravenous hydration is 
not practical or safe. Inhaled bronchodilators exert 
their effect following absorption into the circulation. 
Absorption from the pulmonary system is rapid and 
the degree of bronchodilation obtained will be equal 
to that of an intravenous dose with similar blood 
levels. Vasoconstrictors may be administered by 
aerosol primarily for their topical properties. Many 
acute pulmonary diseases a re accompanied by an 
inflammatory reaction of the respiratory mucosa 
which includes profound capillary congestion and 
swelling. Topical application of a vasoconstrictor 
may have dramatic effei:ts in decreasing the hyper-
emia and increasi ng lumen size. Racemic epinephrine 
is a very effective topical vasoconstrictor and a mild 
systemic bronchodilator. It may be of significant ben-
efit as adjunctive t~erapy to intravenous theo-
phylline. Choice of nebulizing devices for any of these 
medications should be made by assessing the pa-
tient's clinical status and the ability of the patient to 
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generate adequate tidal volumes. We prefer that a 
hand-held nebulizer be used since these devices are 
inexpensive and are powered from a readily available 
compressed air source. There is evidence of improved 
distribution of particles when spontaneous in-
spiration is used with these nebulizers in contrast to 
medication delivered via intermittent positive pres-
sure breathing (I PPB). These attempts at reducing 
airway resistance may be applied in conjunction with 
"expansion" therapy. Incentive spirometry appears 
to be superior to IPPB for preventing and treating 
atelectasis. 
Despite the above measures (controlled oxygen 
administration, aerosolized medications, aggressive 
management of secretions, and expansion therapy) a 
number of patients with acute respiratory failure due 
to increased airway resistance will require intubation 
and mechanical ventilation. A volume-cycled ventila-
tor is the modality of choice in acute respiratory 
failure. We follow the usual guidelines of 15 cc tidal 
volume/ kg of body weight, respiratory rate of 15 
times per minute and F 10 2 of 40% for initial setting. 
Twenty minutes to a half hour after beginning me-
chanical ventilation, the arterial blood gases are re-
peated and adjustments are made as necessary. Be-
cause the basic problem with these patients is varying 
degrees o f a irway resistance in different areas of the 
lung, it is advisable to use as low an inspiratory flow 
rate as is consistent with the patient's ventilatory 
pattern . This promotes gas delivery to poorly venti-
lated regions rather than over-expansion of well-ven-
tilated regions. It is also important to provide for 
sufficient expiratory time. If too short a period is 
allowed for expiration, hyperinflation of the patient's 
lungs beca use of gas trapping may result. A most 
useful r.ecent addition to our therapeutic techniques is 
intermittent mandatory ventilation (IMV). A circuit 
of constant gas flow is added in parallel to the pa-
tient's ventilator allowing the patient to breathe 
spontaneously at his or her own tidal volume between 
pre-set breaths delivered by the volume ventilator. 
This system minimizes the possibility of excessive 
mechanical ventilation and allows better acid-base 
control. As the patient's clinical condition improves, 
the respirator rate may be gradually reduced, pro-
moting a smoother weaning period . Complications 
that may develop in patients on ventilators include 
atelectasis in poorly ventilated areas, pneumot)lorax, 
superinfection, or drying of secretions with mucous 
plugging if the inspired atmosphere is not properly 
humidified. 
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Hypoxemic Hypocapneic Respiratory Failure 
This blood gas pattern is found in syndromes in 
which the pulmonary parenchyma has been dam-
aged. The severity of the condition will be apparent 
when there is a minimal increase in arterial oxygen 
tension in response. to an F10 2 of .4 or above. This 
documents the presence of right-to-left shunting of 
blood. The reduction of parenchymal compliance in 
these patients makes the selection of tidal volumes 
more complex than in those with obstructive prob-
lems. The pressure volume curve of the respiratory 
system may be determined at the time the patient is 
placed on mechanical ventilation. We are often able 
to identify a point in the curve above which a slight 
increase in tidal volume produces a dramatic increase 
in intrathoracic pressure. This may occur at a tidal 
volume as low as .7 liters. If one arbitrarily applies 
the rule of 15 cc/ kg to these patients, the thoracic 
capacity may be exceeded and there will be an in-
appropriately high intrathoracic pressure relative tp 
the effective tidal volume. An appropriate minute 
ventilation may · be delivered by reducing the tidal 
volume and increasing the rate of ventilation. This 
will reduce mean intrathoracic pressure and reduce 
the incidence of barotrauma. 
Most patients in this category who are gravely ill 
will remain hypoxemic despite the increased F10 2 
and mechanical ventilation. These modalities po not 
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reverse the primary defect of reduced Functional Re-
sidual Capacity. This problem may be partially cor-
rected by increasing the distending pressure within 
the thorax. This is done by applying positive end 
expiratory pressure (PEEP). Com'plications include a 
reduction in cardiac output and pneumothorax. It 
should be noted, however, that the occurrence of 
pneumothorax is related to the level of me(ln intra-
thoracic pressure during mechanical ventilation and 
not to the presence or absence of PEEP. 
In . summary, respiratory therapy should be 
thought of as a series of specific steps designed to 
treat the anatomic and physiologic alterations that 
occur with the various forms of respiratory failure, 
The scientific basis of the field is rapidly advancing as 
more is learned about the mechanisms of pulmonary 
disease. Respiratory therapy should no longer be 
equated solely with IPPB but should be regarded as a 
field encompassing a number of effective treatment 
modalities. 
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